Journals / Cumhuriyet Science Journal / 2023 / Cilt: 44 - Sayı: 1

Structural, Electronic, ADME and p450 Analyses of Boron Containing Compounds against Omicron Variant (B.1.1.529) in SARS-CoV-2

Pages
72–80
Publication Date
2023-03-26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that compound B7 can be good drug candidate against omicron variant of SARS-CoV-2.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Eight boron compounds are investigated in this study.
📊
Key Findings & Data:Structural and spectral characterization is done at M062X/6-311G(d) level in the water.
💡
Conclusion & Impact:It was found that compound B7 can be good drug candidate against omicron variant of SARS-CoV-2.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Boron-Imine compounds · SARS-CoV-2_Omicron · p450

Abstract

Eight boron compounds are investigated in this study. Structural and spectral characterization is done at M062X/6-311G(d) level in the water. Active sites of these compounds are determined using contour plots of frontier molecular orbital, molecular electrostatic potential (MEP) maps and MEP contour.. Electrophilic and nucleophilic attack regions are determined. We aimed to determine whether boron compounds inhibitor used in the treatment of omicron variant of SARS-CoV-2. Since SARS-CoV-2 is a worldwide health problem, anti-viral properties of studied boron compounds were investigated using in silico techniques. Bioavaliability analyses were performed using ADME and p450. It was found that compound B7 can be good drug candidate against omicron variant of SARS-CoV-2.

🔖

Cite This Article

SAYIN, K., ATASEVEN, H. (2023). Structural, Electronic, ADME and p450 Analyses of Boron Containing Compounds against Omicron Variant (B.1.1.529) in SARS-CoV-2. Cumhuriyet Science Journal, Cilt: 44 - Sayı: 1, 72–80. https://ajindex.com/articles/885421

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Singhal T., A review of coronavirus disease-2019 (COVID-19), Indian J. Pediatr, 87(4) (2020) 281–286
  2. Ataseven H., Sayin K., Tüzün B., Gedikli M.A., Could boron compounds be effective against SARS-CoV-2?, Bratislava Medical Journal, 122(10) (2021) 753-758
  3. Tüzün B., Nasibova T., Garaev E., Sayin K., Ataseven H., Could Peganum harmala be effective in the treatment of COVID-19?, Bratislava Medical Journal, 122(9) (2021) 670-679
  4. Gokalp F., Sayin K., The highly protective natural medical agents against COVID-19, Bratislava Medical Journal 122(9) (2021) 631-635
  5. Cetiner E., Sayin K., Tüzün B., Ataseven H., Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent?, Bratislava Medical Journal, 122(4) (2021) 263-269
  6. Aktaş A., Tüzün B., Aslan R., Sayin K., Ataseven H., New anti-viral drugs for the treatment of COVID-19 instead of favipiravir, Journal of Biomolecular Structure and Dynamics, 39(18) (2021) 7263-7273
  7. Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States. World Health Organization: Headquarters, Geneve, Switzerland, Update #6: 21 January 2022,
  8. Pasa S., Aydın S., Kalaycı S., Boğa M., Atlan M., Bingul M., Şahin F., Temel H., The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities, Journal of Pharmaceutical Analysis, 6 (2016) 39-48
  9. Gömeç M., Yulak F., Gezegen H., Özkaraca M., Sayin K., Ataseven H., Synthesis of diaryl urea derivatives and evaluation of their antiproliferative activities in colon adenocarcinoma, Journal of Molecular Structure, 1254 (2022) 132318
  10. Vanitha U., Elancheran R., Manikandan V., Kabilan S., Krishnasamy K., Design, synthesis, characterization, molecular docking and computational studies of 3-phenyl-2-thioxoimidazolidin-4-one derivatives, Journal of Molecular Structure, 1246 (2021) 131212
  11. Govindarasu M., Ganeshan S, Ansari M.A., Alomary M.N., Alyahya S., Alghamdi S., Almehmadi M., Rajakumar G., Thiruvengadam M., Vaiyapuri M., In silico modeling and molecular docking insights of kaempferitrin for colon cancer-related molecular targets, Journal of Saudi Chemical Society, 25(9) (2021) 101319
  12. GaussView, Version 6.1, Roy Dennington, Todd A. Keith, and John M. Millam, Semichem Inc., Sha